07:00 , Sep 29, 2016 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Nuclear receptor binding protein 2 (NRBP2)

Cancer INDICATION: Liver cancer Patient samples and cell culture studies suggest promoting NRBP2 expression could enhance the sensitivity of hepatocellular carcinoma (HCC) to chemotherapy. In tissue samples from HCC patients, levels of NRBP2 were lower in tumor...